Parallel Advisors’s Nutex Health NUTX Stock Holding History

Parallel Advisors’s Portfolio NUTX Stock Details NUTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$4.61K	Buy	27 +26	+2,600%	+$3.29K	﹤0.01%	3241
2026 Q1	$95	Buy	+1	New	+$123	﹤0.01%	3785

Other funds holding NUTX

Pertento Partners London, United Kingdom $1.86B AUM 53.86% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Winmill & Co Walpole, New Hampshire $452M AUM 56.84% 1-Year Est. Return

Focus Partners Wealth Boston, Massachusetts $97.6B AUM 29.43% 1-Year Est. Return

Parallel Advisors's NUTX Position: Q2 2026 in Review

Parallel Advisors increased its Nutex Health (NUTX) stake by 2,600% in Q2 2026, buying an estimated $3.29K and bringing the position to 27 shares worth $4.61K. The position accounts for ﹤0.01% of the portfolio, ranked #3241.

Parallel Advisors first reported a position in NUTX in Q1 2026 and has held it in 2 quarters since. 154 funds tracked by Wall St. Rank hold NUTX as of Q2 2026.

Parallel Advisors held 27 shares of Nutex Health worth $4.61K as of Q2 2026.
Parallel Advisors bought 26 Nutex Health shares in Q2 2026, an estimated $3.29K.
Nutex Health made up ﹤0.01% of Parallel Advisors's portfolio in Q2 2026, its #3241 holding.
Parallel Advisors first reported a position in Nutex Health in Q1 2026 and has held it in 2 quarters since.
154 funds tracked by Wall St. Rank held Nutex Health as of Q2 2026.

Based on Parallel Advisors's 13F filing for Q2 2026, filed 5 Aug 2026.